GNR
     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -1.3859    1.5384    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6714    1.1259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0430    1.5384    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7575    1.1259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4720    1.5384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1865    1.1259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1865    0.3009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4720   -0.1116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7575    0.3009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0430   -0.1116    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6714    0.3009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3859   -0.1116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3859   -0.9366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6714   -1.3491    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1004   -1.3491    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1004   -2.1741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  2 11  1  0
  3  4  1  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  6
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB02036

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT01627

>  <COMMON_NAME>  (1) 
2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide

$$$$
